These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 12808121)

  • 1. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma.
    Horiuchi A; Imai T; Wang C; Ohira S; Feng Y; Nikaido T; Konishi I
    Lab Invest; 2003 Jun; 83(6):861-70. PubMed ID: 12808121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
    Wang L; Yang L; Luo Y; Zheng Y
    J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of expression of RhoA (RhoC and their effector ROCK-1 with malignant phenotype of ovarian cancer cells in vitro].
    Han ZQ; Zhang AL; Wu MF; Liu YL; Chen G; Li FJ; Gao QL; Liao GN; Lu YP; Wang SX; Ma D
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):385-8. PubMed ID: 15355639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
    Faried A; Faried LS; Usman N; Kato H; Kuwano H
    Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway.
    Sun HW; Tong SL; He J; Wang Q; Zou L; Ma SJ; Tan HY; Luo JF; Wu HX
    World J Gastroenterol; 2007 Jul; 13(25):3517-22. PubMed ID: 17659701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of RhoA and RhoC expression by RNA interference suppresses human colorectal carcinoma growth in vivo.
    Wang H; Zhao G; Liu X; Sui A; Yang K; Yao R; Wang Z; Shi Q
    J Exp Clin Cancer Res; 2010 Sep; 29(1):123. PubMed ID: 20828398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of adenovirus mediated tandem expression of RhoA and RhoC shRNAs in HCT116 cells.
    Liu XP; Wang HB; Yang K; Sui AH; Shi Q; Qu S
    J Exp Clin Cancer Res; 2009 Apr; 28(1):52. PubMed ID: 19374769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MLK-related kinase (MRK) is a novel RhoC effector that mediates lysophosphatidic acid (LPA)-stimulated tumor cell invasion.
    Korkina O; Dong Z; Marullo A; Warshaw G; Symons M; Ruggieri R
    J Biol Chem; 2013 Feb; 288(8):5364-73. PubMed ID: 23319595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
    Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
    J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer.
    Kamai T; Tsujii T; Arai K; Takagi K; Asami H; Ito Y; Oshima H
    Clin Cancer Res; 2003 Jul; 9(7):2632-41. PubMed ID: 12855641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific induction of migration and invasion of pancreatic carcinoma cells by RhoC, which differs from RhoA in its localisation and activity.
    Dietrich KA; Schwarz R; Liska M; Grass S; Menke A; Meister M; Kierschke G; Längle C; Genze F; Giehl K
    Biol Chem; 2009 Oct; 390(10):1063-77. PubMed ID: 19642867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian clear cell carcinomas: RHO GTPases may contribute to explain their singular biologic behavior.
    Canet B; Pons C; Espinosa I; Prat J
    Hum Pathol; 2011 Jun; 42(6):833-9. PubMed ID: 21208644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
    Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
    PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
    Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
    Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of RhoA and RhoC in colorectal carcinoma and its relations with clinicopathological parameters.
    Wang HB; Liu XP; Liang J; Yang K; Sui AH; Liu YJ
    Clin Chem Lab Med; 2009; 47(7):811-7. PubMed ID: 19499974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of RhoA, RhoB and RhoC GTPases in Cell Morphology, Proliferation and Migration in Human Cytomegalovirus (HCMV) Infected Glioblastoma Cells.
    Tseliou M; Al-Qahtani A; Alarifi S; Alkahtani SH; Stournaras C; Sourvinos G
    Cell Physiol Biochem; 2016; 38(1):94-109. PubMed ID: 26741994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas.
    Suwa H; Ohshio G; Imamura T; Watanabe G; Arii S; Imamura M; Narumiya S; Hiai H; Fukumoto M
    Br J Cancer; 1998; 77(1):147-52. PubMed ID: 9459160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A p27(kip1)-binding protein, p27RF-Rho, promotes cancer metastasis via activation of RhoA and RhoC.
    Hoshino D; Koshikawa N; Seiki M
    J Biol Chem; 2011 Jan; 286(4):3139-48. PubMed ID: 21087931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms.
    Healy KD; Hodgson L; Kim TY; Shutes A; Maddileti S; Juliano RL; Hahn KM; Harden TK; Bang YJ; Der CJ
    Mol Carcinog; 2008 May; 47(5):326-37. PubMed ID: 17932950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.